NVO Stock Summary and Trading Ideas (Novo Nordisk A/S | NYSE:NVO)

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

What symbol and exchange does Novo Nordisk A/S shares trade?

Novo Nordisk A/S trades on the NYSE stock market under the symbol NVO.

What is Novo Nordisk A/S stock price doing today?

As of September 4, 2026, NVO stock price declined to $46.60 with 5,324,285 million shares trading.

What is Novo Nordisk A/S's Beta?

NVO has a beta of 1.04, meaning it tends to be more sensitive to market movements. NVO has a correlation of 0.07 to the broad based SPY ETF.

How much is Novo Nordisk A/S worth?

NVO has a market cap of $206.07 billion. This is considered a Mega Cap stock.

How much money does Novo Nordisk A/S make?

Last quarter Novo Nordisk A/S reported $12 billion in Revenue and $.96 earnings per share. This beat revenue expectation by $859 million and exceeded earnings estimates by $.15.

What is the highest and lowest price Novo Nordisk A/S traded in the last 3 year period?

In the last 3 years, NVO traded as high as $148.15 and as low as $35.12.

What are the top ETFs holding Novo Nordisk A/S?

The top ETF exchange traded funds that NVO belongs to (by Net Assets): AVDE, PPH, CNEQ, WCMI, PID.

Is Novo Nordisk A/S (NVO) a good investment?

NVO has underperformed the market in the last year with a price return of -13.7% while the SPY ETF gained +19.8%. However, in the short term, NVO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.8% vs +2.0% return in SPY. But in the last 2 weeks, NVO shares have been beat by the market, returning -0.3% compared to an SPY return of +0.6%.

What are the support and resistance levels for Novo Nordisk A/S (NVO)?

NVO support price is $46.58 and resistance is $48.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVO shares will trade within this expected range on the day.